跳至主要内容
临床试验/ACTRN12613000566730
ACTRN12613000566730招募中未知

In men receiving androgen-deprivation therapy for histologically confirmed prostate cancer, what is the natural course of hot flash symptoms?

A/Professor Henry Woo0 个研究点目标入组 20 人开始时间: 2013年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
o limit 至 o limit(—)
性别
Male

入选标准

  • Men with histologically confirmed and hormone-naive prostate cancer, being commence on androgen-deprivation therapy for the first time.

排除标准

  • Exclusion criteria include previous androgen-deprivation therapy, participant inability to complete a hot flash score independently, and an ECOG status of 2 or more.

研究者

发起方
A/Professor Henry Woo

相似试验

进行中(未招募)
4 期
The effect of intermittent versus continuous androgen deprivation therapy in Chinese patients with advanced prostate cancer: A prospective controlled Trial from ChinaCancer - Prostateprostate cancer
ACTRN12613000107729Changhai Hospital, Second Military Medical University100
进行中(未招募)
1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigeMedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Metastatic prostate cancer
EUCTR2018-004853-26-FITurku University Hospital35
进行中(未招募)
1 期
The effect of androgen deprivation therapy on prostate specific membrane antigen (PSMA)Prostate cancer
EUCTR2017-002345-29-FITurku University Hospital5
进行中(未招募)
Unknown
Testing the addition of new treatments to standard treatment in prostate cancer that has spread to other areas of the bodyMetastatic hormone-sensitive prostate cancerCancer
ISRCTN66357938niversity College London4,914
招募中
不适用
To determine whether androgen deprivation therapy or androgen blockage therapy upregulates receptor activity of Gallium68 Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans for men with castrate resistant prostate cancer.Metastatic Prostate Cancer
ACTRN12617001116314St Vincent's Hospital, Sydney20